Literature DB >> 25833004

Implications of the Institute of Medicine Report: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

J A Wagner1, J R Ball2.   

Abstract

The Institute of Medicine (IOM) released a groundbreaking 2010 report, Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Key recommendations included a harmonized scientific process and a general framework for biomarker evaluation with three interrelated steps: (1) Analytical validation -- is the biomarker measurement accurate? (2) Qualification -- is the biomarker associated with the clinical endpoint of concern? (3) Utilization -- what is the specific context of the proposed use?
© 2015 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25833004     DOI： 10.1002/cpt.129

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  6 in total

1.  Nutrient reference value: non-communicable disease endpoints--a conference report.

Authors:  J R Lupton; J B Blumberg; M L'Abbe; M LeDoux; H B Rice; C von Schacky; A Yaktine; J C Griffiths
Journal:  Eur J Nutr       Date:  2016-03       Impact factor: 5.614

Review 2.  Neuroimaging-based pain biomarkers: definitions, clinical and research applications, and evaluation frameworks to achieve personalized pain medicine.

Authors:  Sean Mackey; Henry T Greely; Katherine T Martucci
Journal:  Pain Rep       Date:  2019-08-07

3.  The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.

Authors:  Grace Hyun J Kim; Jonathan G Goldin; Wendy Hayes; Andrea Oh; Benjamin Soule; Shuyan Du
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

4.  Midday Nap Duration and Hypertension among Middle-Aged and Older Chinese Adults: A Nationwide Retrospective Cohort Study.

Authors:  Jialin Fu; Xinge Zhang; Justin B Moore; Bowen Wang; Rui Li
Journal:  Int J Environ Res Public Health       Date:  2021-04-01       Impact factor: 3.390

5.  Patient and Family Caregiver's Neuroticism and Conscientiousness Personality in Relation to Quality of Life of Patient With Parkinson's Disease: A Cross-Sectional Study Neuroticism and Conscientiousness Personality in Relation to QoL of Patient With PD.

Authors:  Xiaoye Ma; Guilin Meng; Yan Tan; Xiaohui Liu; Yichen Zhao; Jia Yu; Aiping Jin; Yanxin Zhao; Xueyuan Liu
Journal:  Front Neurol       Date:  2018-09-11       Impact factor: 4.003

6.  A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease.

Authors:  Rana Nagarkatti; David Acosta; Nirmallya Acharyya; Fernanda Fortes de Araujo; Silvana Maria Elói-Santos; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Alain Debrabant
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.